Tuberculosis and the risk of opportunistic infections and cancers in HIV-infected patients starting ART in Southern Africa

Tropical Medicine and International Health

Volumn 18, Issue 2, 2013, Pages 194-198

  Fenner, Lukas ^a   Reid, Stewart E ^b,c   Fox, Matthew P ^d,e   Garone, Daniela ^f   Wellington, Maureen ^g   Prozesky, Hans ^h   Zwahlen, Marcel ^a   Schomaker, Michael ⁱ   Wandeler, Gilles ^a,j   Kancheya, Nzali ^b   Boulle, Andrew ⁱ   Wood, Robin ⁱ   Henostroza, German ^b,k   Egger, Matthias ^a,i  

^a UNIVERSITY OF BERN   (Switzerland)

^b CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA   (Zambia)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^f MÉDECINS SANS FRONTIÈRES   (Switzerland)

^g Newlands Clinic   (Zambia)

^h STELLENBOSCH UNIVERSITY   (South Africa)

ⁱ UNIVERSITY OF CAPE TOWN   (South Africa)

^j UNIVERSITY OF BERN   (Switzerland)

^k University of Alabama at Birmingham   (United States)

more..

Author keywords

Antiretroviral treatment programmes; Cancer; History of tuberculosis; HIV; Opportunistic infections; Risk factors; Tuberculosis

Indexed keywords

CANCER; DISEASE TREATMENT; HUMAN IMMUNODEFICIENCY VIRUS; INFECTIVITY; PNEUMONIA; RISK FACTOR; TUBERCULOSIS;

ADULT; AFRICA; ARTICLE; CD4 LYMPHOCYTE COUNT; CRYPTOCOCCOSIS; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NONHODGKIN LYMPHOMA; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS JIROVECI; PNEUMONIA; TUBERCULOSIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HUMANS; INCIDENCE; MALE; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SOUTH AFRICA; TUBERCULOSIS; YOUNG ADULT;

SOUTH AFRICA; ZAMBIA; ZIMBABWE;

PNEUMOCYSTIS JIROVECII;

EID: 84872676379     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/tmi.12026     Document Type: Article

References (23)

1. Boulle A, Van Cutsem G, Hilderbrand K et al. (2010) Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa. AIDS 24, 563-572.
2. Brinkhof MW, Egger M, Boulle A et al. (2007) Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries. Clinical Infectious Diseases 45, 1518-1521.
3. Corbett EL, Blumberg L, Churchyard GJ et al. (1999) Nontuberculous mycobacteria. Defining disease in a prospective cohort of South African miners. American Journal of Respiratory and Critical Care Medicine 160, 15-21.
4. Corbett EL, Churchyard GJ, Charalambos S et al. (2002) Morbidity and mortality in South African gold miners: impact of untreated disease due to human immunodeficiency virus. Clinical Infectious Diseases 34, 1251-1258.
5. Egger M, Ekouevi DK, Williams C et al. (2011) Cohort Profile: The international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa. International Journal of Epidemiology 41, 1256-1264.
6. Ehrlich RI, Adams S, Baatjies R & Jeebhay MF (2011) Chronic airflow obstruction and respiratory symptoms following tuberculosis: a review of South African studies. Int J Tuberc Lung Dis 15, 886-891.
7. Ernst JD (2012) The immunological life cycle of tuberculosis. Nature Reviews Immunology 12, 581-591.
8. Fenner L, Forster M, Boulle A et al. (2011) Tuberculosis in HIV programmes in lower-income countries: practices and risk factors. International Journal of Tuberculosis and Lung Disease 15, 620-627.
9. Havlir DV & Barnes PF (1999) Tuberculosis in patients with human immunodeficiency virus infection. New England Journal of Medicine 340, 367-373.
10. Holmes CB, Losina E, Walensky RP, Yazdanpanah Y & Freedberg KA (2003) Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa. Clinical Infectious Diseases 36, 652-662.
11. Jarvis JN, Harrison TS, Corbett EL, Wood R & Lawn SD (2010) Is HIV-associated tuberculosis a risk factor for the development of cryptococcal disease? AIDS 24, 612-614.
12. 3. Journal of Infectious Diseases 203, 992-1001.
13. Lawn SD (2004) AIDS in Africa: the impact of coinfections on the pathogenesis of HIV-1 infection. The Journal of Infection 48, 1-12.
14. Lawn SD, Myer L, Bekker LG & Wood R (2006) Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS 20, 1605-1612.
15. Lawn SD, Harries AD, Anglaret X, Myer L & Wood R (2008) Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 22, 1897-1908.
16. Miguez-Burbano MJ, Ashkin D, Rodriguez A et al. (2005) Increased risk of Pneumocystis carinii and community-acquired pneumonia with tobacco use in HIV disease. International Journal of Infectious Diseases 9, 208-217.
17. Morris A, Beard CB & Huang L (2002) Update on the epidemiology and transmission of Pneumocystis carinii. Microbes and Infection 4, 95-103.
18. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG & Chiller TM (2009) Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23, 525-530.
19. Pasipanodya JG, Miller TL, Vecino M et al. (2007) Pulmonary impairment after tuberculosis. Chest 131, 1817-1824.
20. Penner C, Roberts D, Kunimoto D, Manfreda J & Long R (1995) Tuberculosis as a primary cause of respiratory failure requiring mechanical ventilation. American Journal of Respiratory and Critical Care Medicine, 151 (3 Pt 1), 867-872.
21. Shafer RW & Edlin BR (1996) Tuberculosis in patients infected with human immunodeficiency virus: perspective on the past decade. Clinical Infectious Diseases 22, 683-704.
22. Wallis RS, Vjecha M, Amir-Tahmasseb M et al. (1993) Influence of tuberculosis on human immunodeficiency virus (HIV-1): enhanced cytokine expression and elevated beta 2-microglobulin in HIV-1-associated tuberculosis. Journal of Infectious Diseases 167, 43-48.
23. van Zyl Smit RN, Pai M, Yew WW et al. (2010) Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD (Perspective). European Respiratory Journal 35, 27-33.